Finn McKenty Data Reveals Multi-Billion Dollar Peptide Market Trends and Brand Shifts
Published: July 11, 2026 19:47
Author: Jason Moreau
Abstract: Finn McKenty’s data reveals the peptide market is surging past $4.5 billion, driven by anti-aging and wellness applications. Key trends include a shift from generic to patented, high-purity brands (e.g., Semaglutide vs. BPC-157), with strict FDA/EMA certifications now critical for consumer trust. Technical advantages (bioavailability, stability) favor lyophilized peptides over liquid forms, while logistics require cold-chain compliance. Brand differentiation hinges on third-party lab testing and transparent sourcing. The industry faces regulatory fragmentation, yet demand for clinical-grade peptides in longevity and metabolic health fuels a projected 8.9% CAGR through 2030.